256 related articles for article (PubMed ID: 35708837)
21. [The analysis of long-term prognostic factors after laparoscopic liver resection for intrahepatic cholangiocarcinoma and establishment of survival Nomogram model].
Shen ZF; Chen C; Geng ZM; Mao XH; Li JD; Song TQ; Sun CD; Wu H; Cheng ZJ; Lin RX; He Y; Zhai WL; Tang D; Tang ZH; Liang X
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):939-947. PubMed ID: 36207983
[No Abstract] [Full Text] [Related]
22. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
Park HJ; Park B; Park SY; Choi SH; Rhee H; Park JH; Cho ES; Yeom SK; Park S; Park MS; Lee SS
Eur Radiol; 2021 Nov; 31(11):8638-8648. PubMed ID: 33890153
[TBL] [Abstract][Full Text] [Related]
23. Diffusion-weighted imaging as an imaging biomarker for assessing survival of patients with intrahepatic mass-forming cholangiocarcinoma.
Promsorn J; Eurboonyanun K; Chadbunchachai P; Apivatanasiri C; Wirasorn K; Chindaprasirt J; Sookprasert A; Harisinghani M
Abdom Radiol (NY); 2022 Aug; 47(8):2811-2821. PubMed ID: 35704070
[TBL] [Abstract][Full Text] [Related]
24. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.
Asayama Y; Yoshimitsu K; Irie H; Tajima T; Nishie A; Hirakawa M; Nakayama T; Kakihara D; Taketomi A; Aishima S; Honda H
Radiology; 2006 Jan; 238(1):150-5. PubMed ID: 16304089
[TBL] [Abstract][Full Text] [Related]
25. Radiomics nomogram based on optimal VOI of multi-sequence MRI for predicting microvascular invasion in intrahepatic cholangiocarcinoma.
Ma X; Qian X; Wang Q; Zhang Y; Zong R; Zhang J; Qian B; Yang C; Lu X; Shi Y
Radiol Med; 2023 Nov; 128(11):1296-1309. PubMed ID: 37679641
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
28. Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma.
Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H
Abdom Radiol (NY); 2024 Feb; 49(2):425-436. PubMed ID: 37889266
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Tang YY; Zhao YN; Zhang T; Chen ZY; Ma XL
World J Gastroenterol; 2021 Nov; 27(41):7173-7189. PubMed ID: 34887636
[TBL] [Abstract][Full Text] [Related]
30. Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma.
Rhee H; Choi SH; Park JH; Cho ES; Yeom SK; Park S; Han K; Lee SS; Park MS
Liver Int; 2022 Apr; 42(4):930-941. PubMed ID: 35152534
[TBL] [Abstract][Full Text] [Related]
31. Imaging features based on CT and MRI for predicting prognosis of patients with intrahepatic cholangiocarcinoma: a single-center study and meta-analysis.
Sun D; Xu Z; Cao S; Wu H; Lu M; Xu Q; Wang K; Ji G
Cancer Imaging; 2023 Jun; 23(1):56. PubMed ID: 37287062
[TBL] [Abstract][Full Text] [Related]
32. Apparent diffusion coefficient value of mass-forming intrahepatic cholangiocarcinoma: a potential imaging biomarker for prediction of lymph node metastasis.
Zhou Y; Zhou G; Gao X; Xu C; Wang X; Xu P
Abdom Radiol (NY); 2020 Oct; 45(10):3109-3118. PubMed ID: 32107582
[TBL] [Abstract][Full Text] [Related]
33. Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma.
Guo K; Lou Y; Zheng S
Biomed Res Int; 2023; 2023():6638755. PubMed ID: 36704724
[TBL] [Abstract][Full Text] [Related]
34. Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models.
Doussot A; Groot-Koerkamp B; Wiggers JK; Chou J; Gonen M; DeMatteo RP; Allen PJ; Kingham TP; D'Angelica MI; Jarnagin WR
J Am Coll Surg; 2015 Aug; 221(2):452-61. PubMed ID: 26206643
[TBL] [Abstract][Full Text] [Related]
35. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?
Zhou Y; Wang X; Xu C; Zhou G; Liu X; Gao S; Xu P
J Magn Reson Imaging; 2019 Jul; 50(1):315-324. PubMed ID: 30444023
[TBL] [Abstract][Full Text] [Related]
36. Preoperative Computed Tomography Features of Intrahepatic Cholangiocarcinoma for Predicting Lymph Node Metastasis and Overall Survival.
Zhu Y; Mao Y; Chen J; Qiu Y; Wang Z; He J
J Comput Assist Tomogr; 2019; 43(5):729-735. PubMed ID: 31490892
[TBL] [Abstract][Full Text] [Related]
37. A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.
Yeh CN; Wang SY; Chen YY; Chen MH; Chiang KC; Cheng CT; Tsai CY; Wang CC; Yeh TS; Chen TC
Anticancer Res; 2016 Aug; 36(8):4249-58. PubMed ID: 27466540
[TBL] [Abstract][Full Text] [Related]
38. Construction and validation of a novel tumor morphology immune inflammatory nutritional score (TIIN score) for intrahepatic cholangiocarcinoma: a multicenter study.
Zhang H; Huang G; Li Q; Wang Y; Yang Z; Chen P; Yuan H; Chen K; Meng B; Yu H
BMC Cancer; 2024 May; 24(1):630. PubMed ID: 38783240
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
40. Contrast-Enhanced Ultrasound-Based Nomogram: A Potential Predictor of Individually Postoperative Early Recurrence for Patients With Combined Hepatocellular-Cholangiocarcinoma.
Guo HL; Lu XZ; Hu HT; Ruan SM; Zheng X; Xie XY; Lu MD; Kuang M; Shen SL; Chen LD; Wang W
J Ultrasound Med; 2022 Aug; 41(8):1925-1938. PubMed ID: 34751450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
